6 Reasons Drug-Resistant Bacteria Spread Faster in Indian Hospitals

Antimicrobial resistance kills more people globally each year than malaria and HIV combined, and India sits near the top of every burden estimate. The problem is not confined to farms or pharmacies. Hospital wards are where resistant strains find their most efficient route from one patient to the next, and several features of the Indian hospital system make that route shorter than it needs to be.

Many government hospitals in India operate at two to three times their sanctioned bed capacity. When patients share beds, sleep on floor mattresses beside occupied beds, or are attended by multiple family members in an open ward, the physical distance that slows pathogen transmission disappears. Klebsiella pneumoniae carbapenemase-producing strains and New Delhi metallo-beta-lactamase organisms, both first characterised in Indian clinical settings, spread through contact and surface contamination. In a ward where one nurse manages forty patients, the hand-hygiene window between contacts shrinks to near zero.

A culture-and-sensitivity test identifies which organism is causing an infection and which antibiotics can still kill it. The test takes 48 to 72 hours and costs money many patients do not have. In practice, broad-spectrum antibiotics are often started empirically and never narrowed once results could theoretically arrive. The Indian Council of Medical Research has documented through its annual AMR surveillance network that carbapenem resistance in Acinetobacter baumannii, a common hospital-acquired pathogen, has risen sharply in tertiary care centres. Each course of a broad-spectrum drug that does not match the organism selects for resistance in the bacteria that survive it, and those bacteria stay in the ward.

Patients arriving at a hospital have often already taken antibiotics bought over the counter, sometimes the right drug at the wrong dose, sometimes the wrong drug entirely. Pharmacies in India are legally required to dispense prescription antibiotics only on a valid prescription, but enforcement is inconsistent and access to a prescribing doctor in rural areas is genuinely limited. A patient who has taken three days of azithromycin for what turns out to be a resistant respiratory infection arrives at the ward already carrying a partially selected population. The hospital's own flora then meets that population.

Blood pressure cuffs, stethoscopes, pulse oximeters, and IV stands move between patients in busy wards. Proper decontamination between uses requires time, appropriate disinfectants, and staff trained to use them. Where staffing ratios are stretched and disinfectant supply chains are unreliable, equipment becomes a physical bridge between patients. Carbapenem-resistant organisms survive on dry surfaces for days to weeks. A cuff placed on a colonised patient and then on an immunocompromised post-surgical patient does not need to travel far.

Urinary catheters, central venous lines, and endotracheal tubes are necessary in critical care. Each day they remain in place beyond clinical need multiplies the risk of a device-associated infection. Catheter-associated urinary tract infections and central-line-associated bloodstream infections are among the most common hospital-acquired infections globally, and in Indian ICUs the causative organisms are frequently resistant to first- and second-line drugs. Removing a device the day it is no longer needed is one of the most effective resistance-control interventions available, and it costs nothing beyond a protocol and staff time to follow it.

Tertiary teaching hospitals in metro cities have infection-control committees, antibiotic stewardship programmes, and dedicated microbiology departments. District hospitals, nursing homes, and smaller private facilities often do not. Patients who acquire a resistant infection at a smaller facility and are then referred upward carry that strain into a larger hospital's population. The referral chain, which is how the Indian system is designed to function, also moves resistance upstream. Strengthening infection control at the entry point of the chain matters as much as the protocols at the apex institution.

Resistance does not emerge in hospitals because of one failure. It is the product of several pressures acting on the same population of bacteria at the same time. Overcrowding compresses the space for safe practice, culture tests that never get ordered remove the information that would guide treatment, and equipment that moves between patients without decontamination does the rest. Each of these is a system problem with a system solution, which means the question worth asking a treating team is not just which antibiotic, but whether a culture has been sent, when the catheter comes out, and what the ward's decontamination protocol is.